Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

BMS-754807

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

BMS

Drug class:

IGF-1R inhibitor

Related drugs:

IGF1R overexpression	Colorectal Cancer	IGF1R overexpression	Colorectal Cancer	BMS-754807 Sensitive: D – Preclinical BMS-754807 Sensitive : D	BMS-754807 Sensitive: D – Preclinical BMS-754807 Sensitive : D
IGFBP6 underexpression	Colorectal Cancer	IGFBP6 underexpression	Colorectal Cancer	BMS-754807 Sensitive: D – Preclinical BMS-754807 Sensitive : D	BMS-754807 Sensitive: D – Preclinical BMS-754807 Sensitive : D
IR overexpression	Colorectal Cancer	IR overexpression	Colorectal Cancer	BMS-754807 Sensitive: D – Preclinical BMS-754807 Sensitive : D	BMS-754807 Sensitive: D – Preclinical BMS-754807 Sensitive : D
IRS2 amplification	Colorectal Cancer	IRS2 amplification	Colorectal Cancer	BMS-754807 Sensitive: D – Preclinical BMS-754807 Sensitive : D	BMS-754807 Sensitive: D – Preclinical BMS-754807 Sensitive : D
KRAS G13D	Colorectal Cancer	KRAS G13D	Colorectal Cancer	BMS-754807 Resistant: D – Preclinical BMS-754807 Resistant : D	BMS-754807 Resistant: D – Preclinical BMS-754807 Resistant : D
KRAS mutation	Colorectal Cancer	KRAS mutation	Colorectal Cancer	BMS-754807 Sensitive: D – Preclinical BMS-754807 Sensitive : D	BMS-754807 Sensitive: D – Preclinical BMS-754807 Sensitive : D
IRS2 amplification + KRAS mutation	Colorectal Cancer	IRS2 amplification + KRAS mutation	Colorectal Cancer	BMS-754807 Sensitive: D – Preclinical BMS-754807 Sensitive : D	BMS-754807 Sensitive: D – Preclinical BMS-754807 Sensitive : D
IGF1R overexpression + KRAS mutation	Colorectal Cancer	IGF1R overexpression + KRAS mutation	Colorectal Cancer	BMS-754807 Sensitive: D – Preclinical BMS-754807 Sensitive : D	BMS-754807 Sensitive: D – Preclinical BMS-754807 Sensitive : D
IR overexpression + KRAS mutation	Colorectal Cancer	IR overexpression + KRAS mutation	Colorectal Cancer	BMS-754807 Sensitive: D – Preclinical BMS-754807 Sensitive : D	BMS-754807 Sensitive: D – Preclinical BMS-754807 Sensitive : D
BRAF V600E	Colorectal Cancer	BRAF V600E	Colorectal Cancer	BMS-754807 Resistant: D – Preclinical BMS-754807 Resistant : D	BMS-754807 Resistant: D – Preclinical BMS-754807 Resistant : D